Telomerase activity in Hodgkin's disease

被引:42
|
作者
Norrback, KF
Enblad, G
Erlanson, M
Sundström, C
Roos, G [1 ]
机构
[1] Umea Univ, Dept Pathol, S-90187 Umea, Sweden
[2] Umea Univ, Dept Oncol, S-90187 Umea, Sweden
[3] Uppsala Univ, Dept Oncol, Uppsala, Sweden
[4] Uppsala Univ, Dept Pathol, Uppsala, Sweden
关键词
D O I
10.1182/blood.V92.2.567.414a18_567_573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Telomere maintenance executed by the action of telomerase seems to be a prerequisite for immortalization, Telomerase is found in most cell lines and malignant tumors. A telomerase-independent mechanism for telomere maintenance in Hodgkin's disease has been proposed in the absence of detectable telomerase activity, In this study, telomerase activity was detected in 31 of 77 Hodgkin's disease samples and a strong correlation between eosinophilia and absence of detectable telomerase activity was found, Purified eosinophils and specifically eosinophil-derived neurotoxin and eosinophilic cationic protein, bath ribonucleases, were found to degrade telomerase. Purified neutrophils also exhibited weak telomerase degradative activity, Reanalysis of previously telomerase-negative Hodgkin's disease samples with eosinophilia using ribonuclease inhibitors resulted in the detection of telomerase activity. Ribonuclease-containing cells in vivo thus have a considerable impact on the detectability of telomerase. In Hodgkin's disease samples without eosinophilia, 24 of 27 exhibited telomerase activity at decreased levels compared with non-Hodgkin's lymphomas and at increased levels compared with reactive nodes indicative of a telomerase positive tumor component in Hodgkin's disease. Telomerase positivity of the Hodgkin's and Reed-Sternberg cells in vivo was also supported by high levels of telomerase expression in Hodgkin's disease cell lines, Based on our data, Hodgkin's lymphomas are potential targets for antitelomerase therapy. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:567 / 573
页数:7
相关论文
共 50 条
  • [11] Telomerase activity in gestational trophoblastic disease
    Cheung, ANY
    Zhang, DK
    Liu, Y
    Ngan, HYS
    Shen, DS
    Tsao, SW
    JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (08) : 588 - 592
  • [12] Telomerase activity in B-cell non-Hodgkin lymphoma
    Ely, SA
    Chadburn, A
    Dayton, CM
    Cesarman, E
    Knowles, DM
    CANCER, 2000, 89 (02) : 445 - 452
  • [13] Hodgkin s disease
    不详
    BRITISH MEDICAL JOURNAL, 1935, 1935 : 323 - 324
  • [14] Hodgkin s disease
    Wallhauser, A
    ARCHIVES OF PATHOLOGY, 1933, 16 (04): : 522 - 562
  • [16] Hodgkin's disease
    Maslovsky, Igor
    Gefel, Dov
    HAEMATOLOGICA, 2005, 90 : 58 - 58
  • [17] Hodgkin's disease
    Gustafsson, A
    ACTA ONCOLOGICA, 1996, 35 (07) : 93 - 101
  • [18] Hodgkin's disease
    Bunting, CH
    BULLETIN OF THE JOHNS HOPKINS HOSPITAL, 1914, 25 : 177 - 180
  • [19] Hodgkin's disease
    Baker, C
    Mann, WN
    LANCET, 1940, 1 : 23 - 25
  • [20] Hodgkin's disease
    Stein, H
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (01) : 119 - 120